A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants
PHASE1
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )
N/A
Lipoprotein-apheresis DFPP has been performed in patients with Lp(a) levels...
Status
Completed
Location
CHR Metz-Thionville Hopital de Mercy
Start Date
2025-07-01
Trial ID
NCT07390604
Home Management of Malaria and Pneumonia
PHASE4
A well-implemented community-based program of early and appropriate treatme...